AHL Partners’s Bristol-Myers Squibb BMY Stock Holding History

AHL Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$7.07M	Sell	115,364 -8,881	-7%	-$555K	0.11%	350
2017 Q3	$7.92M	Buy	124,245 +52,279	+73%	+$3.05M	0.14%	249
2017 Q2	$4.01M	Buy	71,966 +58,706	+443%	+$3.19M	0.09%	423
2017 Q1	$721K	Buy	+13,260	New	+$727K	0.02%	876
2016 Q4	–	Sell	-6,851	Closed	-$370K	–	1049
2016 Q3	$370K	Buy	6,851 +1,016	+17%	+$65.3K	0.01%	916
2016 Q2	$429K	Buy	5,835 +2,149	+58%	+$152K	0.02%	640
2016 Q1	$236K	Sell	3,686 -22,647	-86%	-$1.43M	0.01%	709
2015 Q4	$1.81M	Buy	26,333 +18,215	+224%	+$1.2M	0.14%	280
2015 Q3	$480K	Sell	8,118 -67,934	-89%	-$4.31M	0.08%	393
2015 Q2	$5.06M	Sell	76,052 -6,777	-8%	-$447K	0.2%	172
2015 Q1	$5.34M	Buy	82,829 +37,777	+84%	+$2.36M	0.21%	148
2014 Q4	$2.66M	Buy	45,052 +39,554	+719%	+$2.23M	0.14%	308
2014 Q3	$281K	Buy	+5,498	New	+$275K	0.02%	607

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AHL Partners's BMY Position: Q4 2017 in Review

AHL Partners reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q4 2017, selling an estimated $555K and leaving 115,364 shares worth $7.07M. The position accounts for 0.11% of the portfolio, ranked #350.

AHL Partners first reported a position in BMY in Q3 2014 and has held it in 13 quarters since. The position peaked at $7.92M in Q3 2017. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

AHL Partners held 115,364 shares of Bristol-Myers Squibb worth $7.07M as of Q4 2017.
AHL Partners sold 8,881 Bristol-Myers Squibb shares in Q4 2017, an estimated $555K.
Bristol-Myers Squibb made up 0.11% of AHL Partners's portfolio in Q4 2017, its #350 holding.
AHL Partners first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 13 quarters since.
AHL Partners's Bristol-Myers Squibb position peaked at $7.92M in Q3 2017.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.